Therapeutic Areas / All therapeutic areas
Your needs,
our answers
Alfasigma is a leading player in the Italian pharmaceutical industry, with a massive presence in international markets and a wide range of products entrusted to a network of distributors that guarantee their distribution.
With more than 75 years of history, the Company has a longstanding track record in developing innovative therapeutic indications to meet the new needs of patients while renewing and consolidating its existing products. Its mission is to improve people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.
Alfasigma's diverse portfolio includes prescription medications, over-the-counter products, and nutraceuticals.
Worldwide, the main therapeutic areas are Gastroenterology and Vascular as well as Rheumatology, Metabolic, Nutraceuticals, and Medical Foods.
Gastroenterology
Gastrointestinal therapeutics are our specialty. Everyday we strive to give a concrete answer to functional gastro-intestinal disorders, IBD (Inflammatory Bowel Disease), gastro-oesophageal reflux disorder, hepatic encephalopathy and chronic liver disease (cirrhosis), Ulcerative Colitis, PBC (Primary Biliary Cholangitis)
Vascular
Vascular investigation is a company corporate mission. Venous diseases, lower extremity artery disease, diabetic microangiopathies are the main pathologies in which we offer solutions
Rheumatology
We provide treatments to relieve symptoms and signs in patients affected by rheumatoid arthritis
Metabolic
In the metabolic area, our R&D has developed Carnitine, an amino acid derivative whose insufficiency can impair the metabolism of essential tissues, such as those of the heart and muscles
Nutraceuticals & Medical foods
With our supplements, we are responding to the demand for a vast range of elements aimed at neural tissue well-being, recovery of muscle tone and combating physical and mental fatigue
Read More
Our Research & Development Department is focused on three main therapeutic areas: gastroenterology, vascular disease & neuroscience disorders.
We’re looking for trailblazers to help lead this exciting transformation—creative, entrepreneurial, and collaborative builders ready to make an impact.
Morpho is a distinctive Contract Development and Manufacturing Organisation (CDMO) of Alfasigma, providing end-to-end pharmaceutical and nutraceutical solutions tailored to our partners' needs worldwide.